ERIS LIFESCIENCES
Back to Cashflow Statement
|
ERIS LIFESCIENCES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-145 Cr | ₹104 Cr | ₹11 Cr | ₹-2.34 Cr | ₹14 Cr |
What is the latest Net Cash Inflow / Outflow ratio of ERIS LIFESCIENCES ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹-145 Cr |
| Mar2025 | ₹104 Cr |
| Mar2024 | ₹11 Cr |
| Mar2023 | ₹-2.34 Cr |
| Mar2022 | ₹14 Cr |
How is Net Cash Inflow / Outflow of ERIS LIFESCIENCES Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹-145 Cr | Negative | |
| Mar2025 | ₹104 Cr | 828.56 | |
| Mar2024 | ₹11 Cr | Positive | |
| Mar2023 | ₹-2.34 Cr | Negative | |
| Mar2022 | ₹14 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of ERIS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ERIS LIFESCIENCES | ₹17,059.4 Cr | 6.1% | 3.6% | -24.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,963.0 Cr | 2.7% | 1.4% | 4.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹269,451.0 Cr | 4.5% | 6.3% | 50.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,456.0 Cr | 1.8% | -1.3% | 31.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,664.0 Cr | 0.8% | 12.5% | 14.1% | Stock Analytics | |
| CIPLA | ₹113,246.0 Cr | 1.6% | 4.4% | -9.1% | Stock Analytics | |
ERIS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ERIS LIFESCIENCES | 6.1% |
3.6% |
-24.8% |
| SENSEX | 7% |
9.6% |
-6.7% |
You may also like the below Video Courses